Business
We are in continuing competition for highly skilled professionals in all of our market areas.
CACI INTERNATIONAL INC /DE/: Revenue grew 12.6% to $8.628B from $7.66B. Net income grew 19.0% to $499.83M from $419.924M. Free cash flow grew 11.0% to $481.406M from $433.645M. Operating margin expanded 38 bps to 8.86%. CACI INTERNATIONAL INC /DE/'s principal statistical and annual-change screens add no overriding warning to the reported profit and cash-flow record.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 12.6%OK
- Profitability — Net income grew 19.0% to $499.83M from $419.924MOK
- Cash flow — Free cash flow grew 11.0% to $481.406M from $433.645MOK
- Margins — Operating margin expanded 38 bps to 8.86%OK
- Accounting — No overriding statistical warningNote
- Insiders — 0 purchases and 5 salesNote
Where the revenue comes from
Fiscal 2026, as CACI INTERNATIONAL INC /DE/ reports it. History and quarterly detail are in the app.
- Domestic$9.3B
- International$307.5M
Leadership changes
From CACI INTERNATIONAL INC /DE/'s own filings, the day they're filed.
- Michael Gilday · departureeff. 2026-01-01
- David Keffer · departureeff. 2026-01-01
- Michael A. Daniels · departureeff. 2026-01-01
Latest filings
- 10-K · Annual report2026-08-06
- 8-K · Company announcement2026-08-05
- 8-K · Company announcement2026-06-22
- 8-K · Company announcement2026-06-05
- 10-Q · Quarterly report2026-04-23
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CACI INTERNATIONAL INC /DE/, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.